Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Aug;65(2):416–426.

Immunoglobulin E-dependent stimulation of human alveolar macrophages: significance in type 1 hypersensitivity.

R W Fuller, P K Morris, R Richmond, D Sykes, I M Varndell, D M Kemeny, P J Cole, C T Dollery, J MacDermot
PMCID: PMC1542321  PMID: 2947765

Abstract

Human alveolar macrophages were obtained during diagnostic bronchoalveolar lavage. Cells were cultured, and morphological examination (including electron microscopy) revealed that not more than 5% of the cultured cells were identifiable as cells other than alveolar macrophages. The cells were sensitized with human myeloma immunoglobulin E. and then challenged with anti-immunoglobulin E anti-sera. The experiments employed a highly specific monoclonal antibody and three affinity purified reagents. The formation of immunoglobulin E/anti-immunoglobulin E complexes facilitated release from alveolar macrophages of leukotriene B4, prostaglandin F2 alpha, thromboxane B2 and the lysosomal hydrolase N-acetyl-beta-D-glucosaminidase. There was no release of active oxygen species, with this stimulus, as measured by lucigenin chemiluminescence. Immunoglobulin E receptors were identified histochemically on the surface of human alveolar macrophages, and were visualized as conjugates with colloidal gold by electron microscopy. These results support the view that human alveolar macrophages may contribute to type 1 hypersensitivity reactions in the lung.

Full text

PDF
416

Images in this article

423Fig. 4
on p.423

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach M. K., Brashler J. R., Hammarström S., Samuelsson B. Identification of leukotriene C-1 as a major component of slow-reacting substance from rat mononuclear cells. J Immunol. 1980 Jul;125(1):115–117. [PubMed] [Google Scholar]
  2. Boltz-Nitulescu G., Spiegelberg H. L. Receptors specific for IgE on rat alveolar and peritoneal macrophages. Cell Immunol. 1981 Mar 15;59(1):106–114. doi: 10.1016/0008-8749(81)90438-x. [DOI] [PubMed] [Google Scholar]
  3. Farnam J., Grant J. A., Lett-Brown M. A., Hunt C., Thueson D. O., Giclas P. C. Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism. J Immunol. 1985 Jan;134(1):541–547. [PubMed] [Google Scholar]
  4. Fels A. O., Pawlowski N. A., Cramer E. B., King T. K., Cohn Z. A., Scott W. A. Human alveolar macrophages produce leukotriene B4. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7866–7870. doi: 10.1073/pnas.79.24.7866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fuller R. W., Kelsey C. R., Cole P. J., Dollery C. T., MacDermot J. Dexamethasone inhibits the production of thromboxane B2 and leukotriene B4 by human alveolar and peritoneal macrophages in culture. Clin Sci (Lond) 1984 Dec;67(6):653–656. doi: 10.1042/cs0670653. [DOI] [PubMed] [Google Scholar]
  6. Greening A. P., Lowrie D. B. Extracellular release of hydrogen peroxide by human alveolar macrophages: the relationship to cigarette smoking and lower respiratory tract infections. Clin Sci (Lond) 1983 Dec;65(6):661–664. doi: 10.1042/cs0650661. [DOI] [PubMed] [Google Scholar]
  7. Halliwell B. Production of superoxide, hydrogen peroxide and hydroxyl radicals by phagocytic cells: a cause of chronic inflammatory disease? Cell Biol Int Rep. 1982 Jun;6(6):529–542. doi: 10.1016/0309-1651(82)90175-8. [DOI] [PubMed] [Google Scholar]
  8. Hassner A., Saxon A. Inhibition of ongoing myeloma IgE synthesis in vitro by activated human T cells. J Immunol. 1983 Apr;130(4):1567–1572. [PubMed] [Google Scholar]
  9. Holgate S. T., Burns G. B., Robinson C., Church M. K. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. J Immunol. 1984 Oct;133(4):2138–2144. [PubMed] [Google Scholar]
  10. Ishizaka K., Ishizaka T., Hornbrook M. M. Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J Immunol. 1966 Jul;97(1):75–85. [PubMed] [Google Scholar]
  11. Ishizaka K., Ishizaka T., Hornbrook M. M. Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. J Immunol. 1966 Dec;97(6):840–853. [PubMed] [Google Scholar]
  12. Ishizaka K., Ishizaka T. Induction of erythema-wheal reactions by soluble antigen-gammaE antibody complexes in humans. J Immunol. 1968 Jul;101(1):68–78. [PubMed] [Google Scholar]
  13. Ishizaka K., Tomioka H., Ishizaka T. Mechanisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes. J Immunol. 1970 Dec;105(6):1459–1467. [PubMed] [Google Scholar]
  14. Ishizaka T., König W., Kurata M., Mauser L., Ishizaka K. Immunologic properties of mast cells from rats infected with Nippostrongylus brasiliensis. J Immunol. 1975 Oct;115(4):1078–1083. [PubMed] [Google Scholar]
  15. Joseph M., Tonnel A. B., Capron A., Voisin C. Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E. Clin Exp Immunol. 1980 May;40(2):416–422. [PMC free article] [PubMed] [Google Scholar]
  16. Joseph M., Tonnel A. B., Torpier G., Capron A., Arnoux B., Benveniste J. Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. J Clin Invest. 1983 Feb;71(2):221–230. doi: 10.1172/JCI110762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kunkel S. L., Duque R. E. The macrophage adherence phenomenon: its relationship to prostaglandin E2 and superoxide anion production and changes in transmembrane potential. Prostaglandins. 1983 Dec;26(6):893–904. doi: 10.1016/0090-6980(83)90152-1. [DOI] [PubMed] [Google Scholar]
  18. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  19. Lewis R. A., Austen K. F. Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compounds. Nature. 1981 Sep 10;293(5828):103–108. doi: 10.1038/293103a0. [DOI] [PubMed] [Google Scholar]
  20. MacDermot J., Kelsey C. R., Waddell K. A., Richmond R., Knight R. K., Cole P. J., Dollery C. T., Landon D. N., Blair I. A. Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. Prostaglandins. 1984 Feb;27(2):163–179. doi: 10.1016/0090-6980(84)90071-6. [DOI] [PubMed] [Google Scholar]
  21. Melewicz F. M., Kline L. E., Cohen A. B., Spiegelberg H. L. Characterization of Fc receptors for IgE on human alveolar macrophages. Clin Exp Immunol. 1982 Aug;49(2):364–370. [PMC free article] [PubMed] [Google Scholar]
  22. Partridge M. R., Saunders K. B. Effect of an inhaled antihistamine (clemastine) as a bronchodilator and as a maintenance treatment in asthma. Thorax. 1979 Dec;34(6):771–776. doi: 10.1136/thx.34.6.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pepys J., Hutchcroft B. J. Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis. 1975 Dec;112(6):829–859. doi: 10.1164/arrd.1975.112.6.829. [DOI] [PubMed] [Google Scholar]
  24. Rankin J. A., Hitchcock M., Merrill W., Bach M. K., Brashler J. R., Askenase P. W. IgE-dependent release of leukotriene C4 from alveolar macrophages. Nature. 1982 May 27;297(5864):329–331. doi: 10.1038/297329a0. [DOI] [PubMed] [Google Scholar]
  25. Salmon J. A., Simmons P. M., Palmer R. M. A radioimmunoassay for leukotriene B4. Prostaglandins. 1982 Aug;24(2):225–235. doi: 10.1016/0090-6980(82)90148-4. [DOI] [PubMed] [Google Scholar]
  26. Scott W. A., Rouzer C. A., Cohn Z. A. Leukotriene C release by macrophages. Fed Proc. 1983 Jan;42(1):129–133. [PubMed] [Google Scholar]
  27. Tomioka M., Ida S., Shindoh Y., Ishihara T., Takishima T. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis. 1984 Jun;129(6):1000–1005. doi: 10.1164/arrd.1984.129.6.1000. [DOI] [PubMed] [Google Scholar]
  28. Tonnel A. B., Joseph M., Gosset P., Fournier E., Capron A. Stimulation of alveolar macrophages in asthmatic patients after local provocation test. Lancet. 1983 Jun 25;1(8339):1406–1408. doi: 10.1016/s0140-6736(83)92356-5. [DOI] [PubMed] [Google Scholar]
  29. Tovey E. R., Chapman M. D., Wells C. W., Platts-Mills T. A. The distribution of dust mite allergen in the houses of patients with asthma. Am Rev Respir Dis. 1981 Nov;124(5):630–635. doi: 10.1164/arrd.1981.124.5.630. [DOI] [PubMed] [Google Scholar]
  30. Whitin J. C., Cohen H. J. Dissociation between aggregation and superoxide production in human granulocytes. J Immunol. 1985 Feb;134(2):1206–1211. [PubMed] [Google Scholar]
  31. Williams A. J., Cole P. J. Investigation of alveolar macrophage function using lucigenin-dependent chemiluminescence. Thorax. 1981 Nov;36(11):866–869. doi: 10.1136/thx.36.11.866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Williams J. D., Lee T. H., Lewis R. A., Austen F. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan. J Immunol. 1985 Apr;134(4):2624–2630. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES